Name | Tavapadon |
---|---|
Synonyms |
1,5-Dimethyl-6-(2-methyl-4-{[3-(trifluoromethyl)-2-pyridinyl]oxy}phenyl)-2,4(1H,3H)-pyrimidinedione
Tavapadon 2,4(1H,3H)-Pyrimidinedione, 1,5-dimethyl-6-[2-methyl-4-[[3-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]- |
Description | Tavapadon (PF 6649751, PF-06649751) is an orally available dopamine D1 receptor partial agonist for treatment of Parkinson's disease. Parkinson Disease Discontinued |
---|---|
References | References 1. PCT Int. Appl. (2014), WO 2014207601 A1 20141231. View Related Products by Target Dopamine Receptor Parkinson Disease |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C19H16F3N3O3 |
Molecular Weight | 391.344 |
Exact Mass | 391.114380 |
LogP | 3.66 |
Index of Refraction | 1.549 |